Antiretroviral treatment outcomes amongst older adults in a large multicentre cohort in South Africa
| dc.contributor.author | Fatti, Geoffrey | en_ZA |
| dc.contributor.author | Mothibi, Eula | en_ZA |
| dc.contributor.author | Meintjes, Graeme | en_ZA |
| dc.contributor.author | Grimwood, Ashraf | en_ZA |
| dc.date.accessioned | 2015-12-20T16:05:15Z | |
| dc.date.available | 2015-12-20T16:05:15Z | |
| dc.date.issued | 2014 | en_ZA |
| dc.description.abstract | Introduction Increasing numbers of patients are starting antiretroviral treatment (ART) at advanced age or reaching advanced age while on ART. We compared baseline characteristics and ART outcomes of older adults (aged ≥55 years) vs. younger adults (aged 25-54 years) in routine care settings in South Africa. METHODS: A multicentre cohort study of ART-naïve adults starting ART at 89 public sector facilities was conducted. Mortality, loss to follow-up (LTFU), immunological and virological outcomes until five years of ART were compared using competing-risks regression, generalised estimating equations and mixed-effects models. RESULTS: 4065 older adults and 86,006 younger adults were included. There were more men amongst older adults; 44.7% vs. 33.4%; RR = 1.34 (95% CI: 1.29-1.39). Mortality after starting ART was substantially higher amongst older adults, adjusted sub-hazard ratio (asHR) = 1.44 over 5 years (95% CI: 1.26-1.64), particularly for the period 7-60 months of treatment, asHR = 1.73 (95% CI: 1.44-2.10). LTFU was lower in older adults, asHR = 0.87 (95% CI: 0.78-0.97). Achievement of virological suppression was greater in older adults, adjusted odds ratio = 1.42 (95% CI: 1.23-1.64). The probabilities of viral rebound and confirmed virological failure were both lower in older adults, adjusted hazard ratios = 0.69 (95% CI: 0.56-0.85) and 0.64 (95% CI: 0.47-0.89), respectively. The rate of CD4 cell recovery (amongst patients with continuous viral suppression) was 25 cells/6 months of ART (95% CI: 17.3-33.2) lower in older adults. CONCLUSIONS: Although older adults had better virological outcomes and reduced LTFU, their higher mortality and slower immunological recovery warrant consideration of age-specific ART initiation criteria and management strategies. | en_ZA |
| dc.identifier.apacitation | Fatti, G., Mothibi, E., Meintjes, G., & Grimwood, A. (2014). Antiretroviral treatment outcomes amongst older adults in a large multicentre cohort in South Africa. <i>PLoS One</i>, http://hdl.handle.net/11427/15916 | en_ZA |
| dc.identifier.chicagocitation | Fatti, Geoffrey, Eula Mothibi, Graeme Meintjes, and Ashraf Grimwood "Antiretroviral treatment outcomes amongst older adults in a large multicentre cohort in South Africa." <i>PLoS One</i> (2014) http://hdl.handle.net/11427/15916 | en_ZA |
| dc.identifier.citation | Fatti, G., Mothibi, E., Meintjes, G., & Grimwood, A. (2013). Antiretroviral treatment outcomes amongst older adults in a large multicentre cohort in South Africa. PloS one, 9(6), e100273. doi:10.1371/journal.pone.0100273 | en_ZA |
| dc.identifier.ris | TY - Journal Article AU - Fatti, Geoffrey AU - Mothibi, Eula AU - Meintjes, Graeme AU - Grimwood, Ashraf AB - Introduction Increasing numbers of patients are starting antiretroviral treatment (ART) at advanced age or reaching advanced age while on ART. We compared baseline characteristics and ART outcomes of older adults (aged ≥55 years) vs. younger adults (aged 25-54 years) in routine care settings in South Africa. METHODS: A multicentre cohort study of ART-naïve adults starting ART at 89 public sector facilities was conducted. Mortality, loss to follow-up (LTFU), immunological and virological outcomes until five years of ART were compared using competing-risks regression, generalised estimating equations and mixed-effects models. RESULTS: 4065 older adults and 86,006 younger adults were included. There were more men amongst older adults; 44.7% vs. 33.4%; RR = 1.34 (95% CI: 1.29-1.39). Mortality after starting ART was substantially higher amongst older adults, adjusted sub-hazard ratio (asHR) = 1.44 over 5 years (95% CI: 1.26-1.64), particularly for the period 7-60 months of treatment, asHR = 1.73 (95% CI: 1.44-2.10). LTFU was lower in older adults, asHR = 0.87 (95% CI: 0.78-0.97). Achievement of virological suppression was greater in older adults, adjusted odds ratio = 1.42 (95% CI: 1.23-1.64). The probabilities of viral rebound and confirmed virological failure were both lower in older adults, adjusted hazard ratios = 0.69 (95% CI: 0.56-0.85) and 0.64 (95% CI: 0.47-0.89), respectively. The rate of CD4 cell recovery (amongst patients with continuous viral suppression) was 25 cells/6 months of ART (95% CI: 17.3-33.2) lower in older adults. CONCLUSIONS: Although older adults had better virological outcomes and reduced LTFU, their higher mortality and slower immunological recovery warrant consideration of age-specific ART initiation criteria and management strategies. DA - 2014 DB - OpenUCT DO - 10.1371/journal.pone.0100273 DP - University of Cape Town J1 - PLoS One LK - https://open.uct.ac.za PB - University of Cape Town PY - 2014 T1 - Antiretroviral treatment outcomes amongst older adults in a large multicentre cohort in South Africa TI - Antiretroviral treatment outcomes amongst older adults in a large multicentre cohort in South Africa UR - http://hdl.handle.net/11427/15916 ER - | en_ZA |
| dc.identifier.uri | http://hdl.handle.net/11427/15916 | |
| dc.identifier.uri | http://dx.doi.org/10.1371/journal.pone.0100273 | |
| dc.identifier.vancouvercitation | Fatti G, Mothibi E, Meintjes G, Grimwood A. Antiretroviral treatment outcomes amongst older adults in a large multicentre cohort in South Africa. PLoS One. 2014; http://hdl.handle.net/11427/15916. | en_ZA |
| dc.language.iso | eng | en_ZA |
| dc.publisher | Public Library of Science | en_ZA |
| dc.publisher.department | Institute of Infectious Disease and Molecular Medicine | en_ZA |
| dc.publisher.faculty | Faculty of Health Sciences | en_ZA |
| dc.publisher.institution | University of Cape Town | |
| dc.rights | This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. | en_ZA |
| dc.rights.holder | © 2014 Fatti et al | en_ZA |
| dc.rights.uri | http://creativecommons.org/licenses/by/4.0 | en_ZA |
| dc.source | PLoS One | en_ZA |
| dc.source.uri | http://journals.plos.org/plosone | en_ZA |
| dc.subject.other | Antiretroviral therapy | en_ZA |
| dc.subject.other | Elderly | en_ZA |
| dc.subject.other | Adults | en_ZA |
| dc.subject.other | Death rates | en_ZA |
| dc.subject.other | Africa | en_ZA |
| dc.subject.other | HIV | en_ZA |
| dc.subject.other | Antiretrovirals | en_ZA |
| dc.subject.other | Viral load | en_ZA |
| dc.title | Antiretroviral treatment outcomes amongst older adults in a large multicentre cohort in South Africa | en_ZA |
| dc.type | Journal Article | en_ZA |
| uct.type.filetype | Text | |
| uct.type.filetype | Image | |
| uct.type.publication | Research | en_ZA |
| uct.type.resource | Article | en_ZA |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- Fatti_Antiretroviral_treatment_outcomes_2014.pdf
- Size:
- 683.91 KB
- Format:
- Adobe Portable Document Format
- Description: